-
SYSTEMATIC LITERATURE REVIEW OF REAL-WORLD EVIDENCE IN RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
Mar 18, 2026, 21:38 PM -
APPLYING ARTIFICIAL INTELLIGENCE TO REAL-WORLD DATA IN NSCLC - TRANSPARENT AND REPRODUCIBLE METHODS FOR PRECISION EVIDENCE
Mar 18, 2026, 21:38 PM -
A FRAMEWORK FOR INCORPORATING DISTANCE-TO-CARE METRICS IN CANCER OUTCOMES RESEARCH: EXPLORATORY INSIGHTS USING REAL-WORLD DATA FROM A NETWORK OF COMMUNITY PRACTICES
Mar 18, 2026, 21:38 PM -
USING AI TO MAP HEOR EVIDENCE GAPS: FINDINGS FROM A LARGE-SCALE LLM-BASED CLASSIFICATION ANALYSIS
Mar 18, 2026, 21:38 PM -
MANAGING LIMITATIONS OF NET PRICE ESTIMATES AT LAUNCH
Mar 18, 2026, 21:38 PM -
CLINICAL CHARACTERISTICS AND TREATMENT PATTERNS IN CISPLATIN ELIGIBLE VERSUS CISPLATIN INELIGIBLE MUSCLE INVASIVE BLADDER CANCER PATIENTS WITH INTENT FOR RESECTION: A MULTICOUNTRY RETROSPECTIVE CHART REVIEW IN EUROPE
Mar 18, 2026, 21:38 PM -
IMPACT OF COVID-19 PANDEMIC ON HEALTHCARE UTILIZATION IN THE US AS OBSERVED IN FEDERATED ELECTRONIC HEALTH RECORDS: 2016 TO 2022
Mar 18, 2026, 21:38 PM -
MEAN OVERALL SURVIVAL FROM THE PHASE 3 MIRASOL TRIAL OF MIRVETUXIMAB SORAVTANSINE VS INVESTIGATOR’S CHOICE OF CHEMOTHERAPY IN WOMEN WITH FR?-HIGH PLATINUM-RESISTANT OVARIAN CANCER (GOG 3045/ENGOT-OV55; NCT04209855)
Mar 18, 2026, 21:38 PM -
CHARACTERIZING THE PATIENTS WITH FIBROMYALGIA: A US REAL-WORLD CLAIMS ANALYSIS
Mar 18, 2026, 21:38 PM -
ASSESSING DRIVERS OF PAYER CONTROL IN RARE DISEASE
Mar 18, 2026, 21:38 PM -
VALIDATION OF AN AI-ASSISTED EVIDENCE SYNTHESIS IN HEOR
Mar 18, 2026, 21:38 PM -
REAL-WORLD SURVIVAL AND PREDICTORS OF MORTALITY IN HEMATOLOGIC MALIGNANCIES DURING AN ERA OF THERAPEUTIC ADVANCEMENT AND HEALTHCARE DISRUPTION: A POPULATION-BASED SEER STUDY
Mar 18, 2026, 21:38 PM -
ASSOCIATION BETWEEN PINEAL NEOPLASM AND ALZHEIMER’S DISEASE PROGRESSION IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT: A POPULATION-BASED COHORT STUDY
Mar 18, 2026, 21:38 PM -
IS CHINA LEADING IN RWE? A SCOPING REVIEW OF RWE GENERATED FROM CHINA HAINAN BOAO LECHENG PILOT ZONE
Mar 18, 2026, 21:38 PM -
REAL-WORLD REFERRAL PATTERNS AND HEALTHCARE UTILIZATION OF HEADACHE DISORDER PATIENTS IN THE UNITED KINGDOM (UK)
Mar 18, 2026, 21:38 PM -
CARDIOVASCULAR RISK STRATIFICATION USING UNSUPERVISED MACHINE LEARNING IN BREAST CANCER PATIENTS, INITIATING ANTHRACYCLINE-BASED TREATMENTS
Mar 18, 2026, 21:38 PM -
FAST&FURIOUSHEOR IMPACT:THE AI ASSISTANT PLAYBOOKTO BUILDTRUSTAND RESILIENCYINTHEFAST-PACED WORLD OFLARGE LANGUAGE MODELS (LLMS)
Mar 18, 2026, 21:38 PM -
CHARACTERIZING AUTOIMMUNE FLARES IN REAL WORLD SETTINGS AMONG INDIVIDUALS WITH RHEUMATOID ARTHRITIS ENROLLED IN AN ONLINE COMMUNITY
Mar 18, 2026, 21:38 PM -
MODELING THE LIFETIME BENEFITS OF ETEPLIRSEN IN PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY
Mar 18, 2026, 21:38 PM -
MACHINE LEARNING TO DIFFERENTIATE CONGESTIVE HEART FAILURE ONSET AMONG HIGH-RISK PATIENTS IDENTIFIED BY THE FRAMINGHAM RISK SCORE
Mar 18, 2026, 21:38 PM
